Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic

Array

Activity Info

Upon completion of the activity, participants should be able to explain the circumstances – and rationale – under which it is appropriate to initiate or switch a patient with inflammatory bowel disease to a biosimilar.
2. Explain the circumstances under which it is appropriate to initiate or switch a patient with inflammatory bowel disease to a biosimilar
Email

CME/CE credit is no longer available for this activity.

Search